A. Arra, D. Coso, and C. G. L. Chagas Guimaraes Layla, “SATB.2 is a sensityive for well differentiated neuroendocrine tumors”, Interamerican Journal of Health Sciences, vol. 1, p. 4, Dec. 2021, doi: 10.59471/ijhsc20214.